Previous studies on brain injury models have revealed heart fatty-acid binding protein (H-FABP) to be a potentially significant brain injury biomarker.[18,19] It has been shown to be located in the heart but also in the brain and described as an interesting diagnostic marker in stroke, Creutzfeldt-Jakob, Alzheimer’s and Parkinson’s diseases, subarachnoid haemorrhage and severe TBI.[18,20–23] In stroke, H-FABP has a rapid increase in concentration with a peak at 3h after symptom onset and thereafter the concentrations remained high for 5 days. Here, FABP3 is linked to Parkinson disease.